These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 24450344)

  • 21. Phase II, randomized study of concomitant chemoradiotherapy followed by surgery and adjuvant capecitabine plus oxaliplatin (CAPOX) compared with induction CAPOX followed by concomitant chemoradiotherapy and surgery in magnetic resonance imaging-defined, locally advanced rectal cancer: Grupo cancer de recto 3 study.
    Fernández-Martos C; Pericay C; Aparicio J; Salud A; Safont M; Massuti B; Vera R; Escudero P; Maurel J; Marcuello E; Mengual JL; Saigi E; Estevan R; Mira M; Polo S; Hernandez A; Gallen M; Arias F; Serra J; Alonso V
    J Clin Oncol; 2010 Feb; 28(5):859-65. PubMed ID: 20065174
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of Preoperative Chemotherapy with Modified OPTIMOX-1 Plus Bevacizumab in Patients with Advanced Rectal Cancer with Factors Contraindicative of Curative Surgery.
    Kosugi C; Koda K; Tanaka K; Suzuki M; Yamazaki M; Shuto K; Matsuo K; Hirano A; Arimitsu H; Shiragami R; Yasuda H
    Hepatogastroenterology; 2015 Jun; 62(140):868-72. PubMed ID: 26902018
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy and safety-in analysis of short-course radiation followed by mFOLFOX-6 plus avelumab for locally advanced rectal adenocarcinoma.
    Shamseddine A; Zeidan YH; El Husseini Z; Kreidieh M; Al Darazi M; Turfa R; Kattan J; Khalifeh I; Mukherji D; Temraz S; Alqasem K; Amarin R; Al Awabdeh T; Deeba S; Jamali F; Mohamad I; Elkhaldi M; Daoud F; Al Masri M; Dabous A; Hushki A; Jaber O; Charafeddine M; Geara F
    Radiat Oncol; 2020 Oct; 15(1):233. PubMed ID: 33028346
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [A case of pathological complete response with neoadjuvant XELOX chemotherapy for locally advanced rectal cancer].
    Kitahara T; Takemasa I; Inoue A; Osawa H; Miyo M; Mokutani Y; Ogawa H; Naito A; Hamabe A; Hiraki M; Munakata K; Uemura M; Nishimura J; Hata T; Mizushima T; Yamamoto H; Doki Y; Mori M
    Gan To Kagaku Ryoho; 2014 Nov; 41(12):1569-71. PubMed ID: 25731255
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Abdominosacral resection: long-term outcome in 86 patients with locally advanced or locally recurrent rectal cancer.
    Bosman SJ; Vermeer TA; Dudink RL; de Hingh IH; Nieuwenhuijzen GA; Rutten HJ
    Eur J Surg Oncol; 2014 Jun; 40(6):699-705. PubMed ID: 24679359
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High-dose radiotherapy (60 Gy) with oral UFT/folinic acid and escalating doses of oxaliplatin in patients with non-resectable locally advanced rectal cancer (LARC): a phase I trial.
    Vestermark LW; Jensen HA; Pfeiffer P
    Acta Oncol; 2012 Mar; 51(3):311-7. PubMed ID: 22248062
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Does pathologic response of rectal cancer influence postoperative morbidity after neoadjuvant radiochemotherapy and total mesorectal excision?
    Maggiori L; Bretagnol F; Aslam MI; Guedj N; Zappa M; Ferron M; Panis Y
    Surgery; 2014 Mar; 155(3):468-75. PubMed ID: 24439750
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [A case of metastatic rectal cancer in an extremely aged patient successfully treated with mFOLFOX6 plus bevacizumab].
    Yokoyama M; Urakawa M; Murakami T; Amano K; Ohsawa T; Okada N; Kumamoto K; Ishibashi K; Ishida H
    Gan To Kagaku Ryoho; 2011 Nov; 38(12):2241-3. PubMed ID: 22202342
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Laparoscopic total pelvic exenteration with en bloc lateral lymph node dissection after neoadjuvant chemoradiotherapy for advanced primary rectal cancer.
    Mukai T; Akiyoshi T; Ueno M; Fukunaga Y; Nagayama S; Fujimoto Y; Konishi T; Ikeda A; Yamaguchi T
    Asian J Endosc Surg; 2013 Nov; 6(4):314-7. PubMed ID: 24308593
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Outcome of abdominosacral resection for locally advanced primary and recurrent rectal cancer.
    Bhangu A; Brown G; Akmal M; Tekkis P
    Br J Surg; 2012 Oct; 99(10):1453-61. PubMed ID: 22961529
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Circumferential resection margin involvement after laparoscopic abdominoperineal excision for rectal cancer.
    Raftopoulos I; Reed JF; Bergamaschi R
    Colorectal Dis; 2012 Apr; 14(4):431-7. PubMed ID: 21689315
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinically-staged T3N0 rectal cancer: is preoperative chemoradiotherapy the optimal treatment?
    Lombardi R; Cuicchi D; Pinto C; Di Fabio F; Iacopino B; Neri S; Tardio ML; Ceccarelli C; Lecce F; Ugolini G; Pini S; Di Tullio P; Taffurelli M; Minni F; Martoni A; Cola B
    Ann Surg Oncol; 2010 Mar; 17(3):838-45. PubMed ID: 20012700
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Phase II trial of neoadjuvant chemotherapy with XELOX plus bevacizumab for locally advanced rectal cancer.
    Uehara K; Ishiguro S; Sakamoto E; Maeda A; Inoue M; Tojima Y; Kobayashi S; Omiya N; Ishizuka N; Nakao A; Goto H; Nagino M
    Jpn J Clin Oncol; 2011 Aug; 41(8):1041-4. PubMed ID: 21803876
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognosis factors for recurrence in patients with locally advanced rectal cancer preoperatively treated with chemoradiotherapy and adjuvant chemotherapy.
    Arredondo J; Baixauli J; Beorlegui C; Arbea L; Rodríguez J; Sola JJ; Chopitea A; Hernández-Lizoáin JL
    Dis Colon Rectum; 2013 Apr; 56(4):416-21. PubMed ID: 23478608
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Evaluation of preoperative radiotherapy or chemoradiotherapy in sphincter preservation for locally advanced middle-low rectal cancer].
    Cao WG; Zhao R; Xi WQ; Ma T; Li H; Xu HP; Che JF; Jin YN
    Zhonghua Zhong Liu Za Zhi; 2007 Mar; 29(3):225-7. PubMed ID: 17649643
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [A long-term survival case of rectal cancer with Virchow's lymph node metastasis by multimodality therapy].
    Hirose H; Ikeda M; Miyoshi N; Kim HM; Okano M; Uemura M; Yamashita S; Takemasa I; Mizushima T; Yamamoto H; Ishii H; Sekimoto M; Doki Y; Mori M
    Gan To Kagaku Ryoho; 2010 Nov; 37(12):2545-7. PubMed ID: 21224634
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Surgical resection after chemotherapy for advanced rectal cancer - report of a case].
    Suda K; Kameyama H; Shimada Y; Sakata J; Kobayashi T; Nogami H; Minagawa M; Kosugi S; Koyama Y; Wakai T
    Gan To Kagaku Ryoho; 2014 Nov; 41(12):1572-4. PubMed ID: 25731256
    [TBL] [Abstract][Full Text] [Related]  

  • 38. What is the incidence of metastatic lymph node involvement after significant pathologic response of primary tumor following neoadjuvant treatment for locally advanced rectal cancer?
    Tranchart H; Lefèvre JH; Svrcek M; Flejou JF; Tiret E; Parc Y
    Ann Surg Oncol; 2013 May; 20(5):1551-9. PubMed ID: 23188545
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [A case of advanced colon cancer successfully treated with combination therapy of cetuximab and oxaliplatin, leucovorin, and 5-fluorouracil].
    Ojima E; Nakano T; Kanamoto A; Sasaki S
    Gan To Kagaku Ryoho; 2013 Nov; 40(12):1962-4. PubMed ID: 24393980
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [A case of advanced rectal cancer that showed complete response to the addition of XELOX+bevacizumab therapy to preoperative chemoradiotherapy with S-1/CPT-11].
    Takahashi T; Namiki K; Matsumoto H; Konno F; Mitsui K; Yoshida R
    Gan To Kagaku Ryoho; 2014 May; 41(5):653-5. PubMed ID: 24917016
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.